«This study demonstrates that targeted fusion - guided biopsy could significantly enhance our ability to identify patients with high - risk
prostate cancers that
need more
aggressive treatment,» says lead author Mohummad Minhaj Siddiqui, MD, assistant professor of surgery at the University of Maryland School of Medicine and director of urologic robotic surgery at the University of Maryland Marlene and Stewart Greenebaum
Cancer Center.
Dr Chris Parker, Chair of the NCRI's
Prostate Cancer Clinical Studies Group, said: «There's a need to develop better tests to identify and monitor men with aggressive prostate
Prostate Cancer Clinical Studies Group, said: «There's a need to develop better tests to identify and monitor men with aggressive prostate c
Cancer Clinical Studies Group, said: «There's a
need to develop better tests to identify and monitor men with
aggressive prostateprostate cancercancer.
Professor Ros Eeles from the Institute of
Cancer Research and The Royal Marsden, who co-leads the prostate cancer ICGC study with Professor Colin Cooper from the ICR and Professors David Neal and Douglas Easton from The University of Cambridge, said: «One of the major challenges in treating prostate cancer is determining who needs aggressive treatment — some are slow growing and will never need treatment whilst others will develop qu
Cancer Research and The Royal Marsden, who co-leads the
prostate cancer ICGC study with Professor Colin Cooper from the ICR and Professors David Neal and Douglas Easton from The University of Cambridge, said: «One of the major challenges in treating prostate cancer is determining who needs aggressive treatment — some are slow growing and will never need treatment whilst others will develop qu
cancer ICGC study with Professor Colin Cooper from the ICR and Professors David Neal and Douglas Easton from The University of Cambridge, said: «One of the major challenges in treating
prostate cancer is determining who needs aggressive treatment — some are slow growing and will never need treatment whilst others will develop qu
cancer is determining who
needs aggressive treatment — some are slow growing and will never
need treatment whilst others will develop quickly.